Categories: News

Nissan Selects IPfolio from Clarivate

Managing IP with advanced workflow automation technology and leading data

- Advertisement -

LONDON, Dec. 18, 2025 /PRNewswire/ — Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced today that Nissan Motor Co., Ltd (Nissan: 7201.T) has selected IPfolio. This intellectual property management software (IPMS) will help Nissan manage and protect its IP more efficiently with advanced workflow automation technology and world-leading data and analytics.

- Advertisement -

With the implementation of IPfolio, Nissan will establish an IPMS that is scalable for the future by developing workflows customized for operations, enhancing data visibility, and enabling integration with other data sources through an Application Programming Interface (API).

- Advertisement -

David Curren, Deputy General Manager of Intellectual Property Department, Nissan Motor Co., Ltd., said: “To address the increasing importance of intellectual property in the automotive industry, Nissan has selected IPfolio from Clarivate to help modernize and streamline its IP operations. The implementation will enable the Nissan IP team to manage its portfolio with greater control, efficiency, and strategic foresight. We are confident that IPfolio will be a key enabler in our mission to protect our intellectual property and strengthen our competitive position.”

- Advertisement -

Maroun S. Mourad, President, Intellectual Property, Clarivate, said: “We are very pleased to support Nissan in transforming the way they manage and protect IP. Blending advanced technologies with decades of IP expertise, our trusted solutions will empower them to elevate IP management, accelerate innovation and mitigate business risk.”

- Advertisement -

About Clarivate 
Clarivate is a leading global provider of transformative intelligence. We offer enriched data, insights & analytics, workflow solutions and expert services in the areas of Academia & Government, Intellectual Property and Life Sciences & Healthcare. For more information, please visit www.clarivate.com

- Advertisement -

Media Contact:
Jack Wan, Director, External Communications
newsroom@clarivate.com

- Advertisement -

Logo – https://mma.prnewswire.com/media/1159266/Clarivate_Logo_v1.jpg

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nissan-selects-ipfolio-from-clarivate-302643654.html

- Advertisement -

Recent Posts

Onco3R Therapeutics Appoints Lawrence Blatt as Chair of the Board for Onco3R Therapeutics

Leuven, Belgium. January 8, 2026. Onco3R Therapeutics, a clinical-stage immunology and oncology biotech company dedicated…

9 hours ago

Engitix Announces $25 Million Series A Extension Financing by Existing Investor Mike Platt to Advance ECM-Targeted Therapeutics in Solid Tumors and Fibrosis

Company has built one of the largest proprietary extracellular matrix (ECM) datasets spanning fibrosis and…

9 hours ago

PathAI and University Hospital Zurich Announce Collaboration to Deploy AISight Dx and AIM-TumorCellularity for Routine Molecular Pathology Workflows

January 08, 2026 03:00 ET  | Source: PathAI BOSTON, Mass. and ZURICH, Switzerland, Jan. 08,…

9 hours ago

The/Nudge Institute Appoints Devadas Krishnan as Chief Development Officer

Bringing over two decades of leadership experience across business development, digital platforms, and venture scale-up, Devadas…

9 hours ago

Hisense Debuts 116UXS and XR10, Advancing RGB MiniLED into a New Era at CES 2026

LAS VEGAS, Jan. 8, 2026 /PRNewswire/ -- Hisense, a leading brand in global consumer electronics…

9 hours ago